Published online before print May 6, 2004, doi: 10.1161/01.STR.0000128018.57526.3a
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2004;35:1375.)
© 2004 American Heart Association, Inc.
Original Contributions |
Stenting of Symptomatic M1 Stenosis of Middle Cerebral Artery
An Initial Experience of 40 Patients
From the Neurovascular Angioplasty Team, Department of Neurology and Neuroradiology, Beijing Tiantan Hospital, Capital University of Medical Sciences, Beijing, China.
Correspondence to Wei-Jian Jiang, MD, Department of Neurology and Neuroradiology, Beijing Tiantan Hospital, Capital University of Medical Sciences, Beijing, 100050, China. E-mail jwj{at}2911.net
Objective— To assess the safety and clinical efficacy of stenting for patients with symptomatic M1 stenosis of middle cerebral artery (MCA), and to assess the significance of classification based on location, morphology, and access of intracranial stenosis (LMA classification) in MCA stenting.
Methods— Forty patients with 42 symptomatic M1 stenoses refractory to medical therapy were enrolled in this study. The lesions were situated at M1 trunk (n=13), M1 origin (n=12), and M1 bifurcation (n=17), respectively, which were classified into type N (nonbifurcation lesions, n=13) and type A (prebifurcation, n=11), B (postbifurcation, n=14), C (lesion across the nonstenotic ostium of its branch, n=1), D (across the stenotic ostium of its branch, n=2), F (combinative lesions of prebifurcation and its small branch ostium, n=1) locations, morphologically into type A (n=15), B (n=23) and C (n=4) lesions, and into type I (mild-to-moderate tortuosity and smooth access, n=17), II (severe tortuosity and/or irregular arterial wall, n=18), and III (excessively severe tortuosity, n=7) accesses.
Results— The technical successful rate was 97.6% for total lesions and 100%, 100%, and 85.7% for types I, II, and III accesses, respectively. The total complication rate was 10%. The mortality was 2.5% (1/40 patients), and 0%, 0%, and 25% for types A, B, and C lesions, respectively. During the median 10 months follow-up, there was no recurrence of transient ischemic attack or stroke in 38 available patients. Among 8 stenting vessels of seven patients with six-month follow-up angiography, 7 showed good patency and one showed restenosis.
Conclusion— Stenting appears to be an effective and feasible therapy for symptomatic M1 stenoses, but also appears to have the higher periprocedural complications, which need strict procedural and periprocedural management to reduce the mortality and morbidity. The LMA classification seems to be helpful to work out the individual therapy and predict the results of stenting. A further study is needed to confirm the benefits of stenting of MCA stenosis.
Key Words: angioplasty • middle cerebral artery • stenosis • stents
This article has been cited by other articles:
 |
|
 |
|
  F. Nahab, M. J. Lynn, S. E. Kasner, M. J. Alexander, R. Klucznik, O. O. Zaidat, J. Chaloupka, H. Lutsep, S. Barnwell, M. Mawad, et al. Risk factors associated with major cerebrovascular complications after intracranial stenting Neurology, June 9, 2009; 72(23): 2014 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Groschel, S. Schnaudigel, S. M. Pilgram, K. Wasser, and A. Kastrup A Systematic Review on Outcome After Stenting for Intracranial Atherosclerosis Stroke, May 1, 2009; 40(5): e340 - e347. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. C. Schumacher, P. M. Meyers, R. T. Higashida, C. P. Derdeyn, S. D. Lavine, G. M. Nesbit, D. Sacks, P. Rasmussen, and L. R. Wechsler Reporting Standards for Angioplasty and Stent-Assisted Angioplasty for Intracranial Atherosclerosis Stroke, May 1, 2009; 40(5): e348 - e365. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Mazighi, J. S. Yadav, and A. Abou-Chebl Durability of Endovascular Therapy for Symptomatic Intracranial Atherosclerosis Stroke, June 1, 2008; 39(6): 1766 - 1769. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Muller-Schunk, J. Linn, N. Peters, M. Spannagl, M. Deisenberg, H. Bruckmann, and T.E. Mayer Monitoring of Clopidogrel-Related Platelet Inhibition: Correlation of Nonresponse with Clinical Outcome in Supra-Aortic Stenting AJNR Am. J. Neuroradiol., April 1, 2008; 29(4): 786 - 791. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fiorella and H. H. Woo Emerging Endovascular Therapies for Symptomatic Intracranial Atherosclerotic Disease Stroke, August 1, 2007; 38(8): 2391 - 2396. [Full Text] [PDF]
|
|
|
|
|
|
W.-J. Jiang, X.-T. Xu, M. Jin, B. Du, K.-H. Dong, and J.-P. Dai Apollo Stent for Symptomatic Atherosclerotic Intracranial Stenosis: Study Results AJNR Am. J. Neuroradiol., May 1, 2007; 28(5): 830 - 834. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. W. Leung, H. Mak, S. C.H. Yu, K.-s. Wong, W.-J. Jiang, and F. Gao Perforator stroke after elective stenting of symptomatic intracranial stenosis Neurology, April 10, 2007; 68(15): 1237 - 1237. [Full Text] [PDF]
|
|
|
|
 |
|
 W.-J. Jiang, B. Du, T. W. Leung, X.-T. Xu, M. Jin, and K.-H. Dong Symptomatic Intracranial Stenosis: Cerebrovascular Complications from Elective Stent Placement Radiology, April 1, 2007; 243(1): 188 - 197. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Fiorella, E. I. Levy, A. S. Turk, F. C. Albuquerque, D. B. Niemann, B. Aagaard-Kienitz, R. A. Hanel, H. Woo, P. A. Rasmussen, L. N. Hopkins, et al. US Multicenter Experience With the Wingspan Stent System for the Treatment of Intracranial Atheromatous Disease: Periprocedural Results Stroke, March 1, 2007; 38(3): 881 - 887. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Jiang, X. T. Xu, B. Du, K. H. Dong, M. Jin, Q. H. Wang, and N. Ma Comparison of elective stenting of severe vs moderate intracranial atherosclerotic stenosis Neurology, February 6, 2007; 68(6): 420 - 426. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Jiang, T. Srivastava, F. Gao, B. Du, K. H. Dong, and X. T. Xu Perforator stroke after elective stenting of symptomatic intracranial stenosis Neurology, June 27, 2006; 66(12): 1868 - 1872. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. P. Marks, J. C. Wojak, F. Al-Ali, M. Jayaraman, M. L. Marcellus, J. J. Connors, and H. M. Do Angioplasty for Symptomatic Intracranial Stenosis: Clinical Outcome Stroke, April 1, 2006; 37(4): 1016 - 1020. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Abou-Chebl, Q. Bashir, and J. S. Yadav Drug-Eluting Stents for the Treatment of Intracranial Atherosclerosis: Initial Experience and Midterm Angiographic Follow-up Stroke, December 1, 2005; 36(12): e165 - e168. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Yoon, J. J. Seo, K. H. Cho, M. K. Kim, B. C. Kim, M. S. Park, T. S. Kim, J. K. Kim, and H. K. Kang Symptomatic Middle Cerebral Artery Stenosis Treated with Intracranial Angioplasty: Experience in 32 Patients Radiology, November 1, 2005; 237(2): 620 - 626. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. O. Zaidat, T. P. Smith, M. J. Alexander, W. Yu, W.S. Smith, V. Singh, N.U. Ko, S.P. Cullen, C.F. Dowd, V.V. Halbach, et al. Long-term outcome of endovascular stenting for symptomatic basilar artery stenosis Neurology, October 25, 2005; 65(8): 1340 - 1341. [Full Text] [PDF]
|
|
|
|
|
|
S. U. Kwon, Y.-J. Cho, J.-S. Koo, H.-J. Bae, Y.-S. Lee, K.-S. Hong, J. H. Lee, and J. S. Kim Cilostazol Prevents the Progression of the Symptomatic Intracranial Arterial Stenosis: The Multicenter Double-Blind Placebo-Controlled Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis Stroke, April 1, 2005; 36(4): 782 - 786. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Pelz, T. Andersson, P. Lylyk, M. Negoro, and M. Soderman Stroke Review: Advances in Interventional Neuroradiology 2004 Stroke, February 1, 2005; 36(2): 211 - 214. [Full Text] [PDF]
|
|
|
|
|
|
K.-C. Chang Editorial Comment--A Mercy to Victims of Cerebrovascular Diseases Stroke, December 1, 2004; 35(12): 2853 - 2854. [Full Text] [PDF]
|
|